iCeutica is developing a pipeline of reformulated and improved products. In addition we work with our pharmaceutical partners to utilize the SoluMatrix platform to improve generics or late stage NCE’s. We also extend the life cycle of selected marketed products by introducing new formulations, combining these products with other drugs or creating new delivery methods, all of which are coupled with renewed patent protection and FDA exclusivity periods.

iCeutica’s SoluMatrix platform provides a simple and scalable process to reformulate and deliver a range of drugs via different routes of administration.

SoluMatrix Technology Feature >

Case Studies >